PVCT Exercise Disclosure
Pershing Edward · SEC Form 4 · Filed Sep 8, 2026
Exercise
Calculated transaction value
$0
Pershing Edward CEO
PVCT
Transaction date
Sep 4, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 4 days later
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D-1 Convertible Preferred Stock on Common Stock
- Quantity / price
- 11,328 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-041727
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT | Exercise | Sep 4, 2026 | Not reported |
| Provectus Biopharmaceuticals, Inc. PVCT Current | Exercise | Sep 4, 2026 | $0 |